Table 1.
Clinical Characteristics
| Ulnar Remodeling Response
|
|||
|---|---|---|---|
| Clinical Characteristic | Below Median (n=26) | Above Median (n=27) | P |
| Age, y | 58±11 | 62±10 | 0.32 |
| Female, % | 8 | 19 | 0.25 |
| Black race, % | 12 | 4 | 0.26 |
| Surgical arm, right/left | 1/25 | 4/23 | 0.19 |
| Body mass index, kg/m2 | 30.2±3.6 | 29.6±6.2 | 0.66 |
| Systolic blood pressure, mm Hg | 136±22 | 129±23 | 0.26 |
| Diastolic blood pressure, mm Hg | 73±11 | 70±8 | 0.35 |
| Glucose, mg/dL | 137±57 | 128±57 | 0.27 |
| Total cholesterol, mg/dL | 187±47 | 169±41 | 0.17 |
| HDL cholesterol, mg/dL | 43±12 | 42±12 | 0.91 |
| Triglycerides, mg/dL | 178±128 | 126±75 | 0.11 |
| LDL cholesterol, mg/dL | 109±30 | 105±34 | 0.66 |
| Creatinine, mg/dL | 0.78±0.20 | 0.84±0.21 | 0.29 |
| White blood count (1000/μL) | 9.1±3.3 | 8.6±2.8 | 0.56 |
| Hemoglobin, g/dL | 12.9±2.3 | 13.2±2.2 | 0.68 |
| Platelet count (1000/μL) | 223±70 | 196±60 | 0.16 |
| Diabetes mellitus, % | 50 | 44 | 0.69 |
| Hypertension, % | 77 | 82 | 0.68 |
| Hypercholesterolemia, % | 92 | 89 | 0.67 |
| Any history of cigarette smoking, % | 85 | 59 | 0.04 |
| Statin treatment, % | 96 | 96 | 0.98 |
| ACE inhibitor treatment, % | 46 | 48 | 0.88 |
| Nitrate treatment, % | 50 | 33 | 0.22 |
| Calcium blocker treatment, % | 12 | 19 | 0.48 |
| Insulin treatment, % | 8 | 15 | 0.41 |
| Aspirin treatment, % | 100 | 100 | 0.99 |
| Unstable presentation, % | 46 | 41 | 0.69 |
ACE indicates angiotensin-converting enzyme.